Head of Aesthetics Strategic Programs
Xiaoming Lin has more than 20 years of experience in developing dermatology products, with a focus on the minimally invasive aesthetic space. She has led the development of many products throughout her career, including work on three neuromodulators and multiple dermal fillers. Prior to her current role, she served as Vice President of Aesthetics Development for Galderma, Vice President of Clinical Research and Development for Anacor and Vice President of Clinical Research and Development for Medicis in the past. She has authored more than 10 manuscripts and numerous peer-reviewed posters.